Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | MME | P08473 | 6/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | TGM2 | P21980 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ACE | P12821 | 1/20 | 0.31 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19963651 | 0.85 | CYP2C9 (0.33) | TGFBR1ALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL30374615 | 0.85 | ALDH1A1 (0.33) | ALDH1A1CYP3A4CYP2C9CYP2C19TSHR | |
| SCHEMBL19951581 | 0.79 | NPSR1 (0.56) | ALDH1A1CYP3A4CYP2C9CYP2C19MME | |
| SCHEMBL23925357 | 0.78 | ALDH1A1 (0.32) | ALDH1A1CYP3A4CYP2C9CYP2C19TGM2 | |
| SCHEMBL6513640 | 0.77 | TGFBR1 (0.52) | TGFBR1ALDH1A1CYP2C19MMETSHR | |
| SCHEMBL6513633 | 0.77 | TGFBR1 (0.52) | TGFBR1ALDH1A1CYP2C19MMETSHR | |
| SCHEMBL19951565 | 0.77 | FOLH1 (0.50) | ALDH1A1CYP3A4CYP2C9CYP2C19MME | |
| SCHEMBL19963562 | 0.76 | ALDH1A1 (0.31) | ALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL24334152 | 0.76 | TSHR (0.37) | ALDH1A1CYP3A4CYP2C9CYP2C19TSHR | |
| SCHEMBL7280005 | 0.75 | TGFBR1 (0.44) | TGFBR1MMEMEN1KMT2AACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023248020-A1 | BLOCK COPOLYMERS GRAFTED TO POROUS POLYMERIC SUBSTRATE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-12-28 | — | — | WO | disclosed |
| EP-3510041-B1 | PROCESSES FOR SEPARATING AGGREGATED PROTEINS FROM MONOMERIC PROTEINS IN A BIOLOGICAL SOLUTION | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-05-31 | — | — | EP | disclosed |
| US-20200368694-A1 | POLYMERIC SUBSTRATES WITH ATTACHED POLYMERIC CHAINS | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2020-11-26 | — | — | US | disclosed |
| EP-3510041-A1 | PROCESSES FOR SEPARATING AGGREGATED PROTEINS FROM MONOMERIC PROTEINS IN A BIOLOGICAL SOLUTION | 3M Innovative Properties Company (US) | 2019-07-17 | — | — | EP | disclosed |
| US-20190194250-A1 | PROCESSES FOR SEPARATING AGGREGATED PROTEINS FROM MONOMERIC PROTEINS IN A BIOLOGICAL SOLUTION | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2019-06-27 | — | — | US | disclosed |
| US-20190194250-A1 | PROCESSES FOR SEPARATING AGGREGATED PROTEINS FROM MONOMERIC PROTEINS IN A BIOLOGICAL SOLUTION | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2019-06-27 | — | — | US | disclosed |
| WO-2018048698-A1 | PROCESSES FOR SEPARATING AGGREGATED PROTEINS FROM MONOMERIC PROTEINS IN A BIOLOGICAL SOLUTION | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-03-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190194250-A1 | PROCESSES FOR SEPARATING AGGREGATED PROTEINS FROM MONOMERIC PROTEINS IN A BIOLOGICAL SOLUTION | PRNP, APBA1, ECPAS | TGFBR1 1331/4885ALDH1A1 4214/4885CYP3A4 4872/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.